InsightfulValue
← Home

Abbott Laboratories
Abbott Laboratories

-12.77%

Healthcare & biotech / Diversified healthcare products


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

More reviews (1)
Abbott Laboratories

πŸ“Š Get full analytics about Abbott Laboratories

Sign up for free or log in

πŸš€ Don’t miss "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

Price
Live  
Infographic
Infographics
Overview
Abbott Laboratories is an American multinational healthcare company that specializes in the development, manufacturing, and sale of pharmaceuticals, medical devices, and diagnostic products. It was founded in 1888 by Chicago physician Wallace Calvin Abbott and has its headquarters in Abbott Park, Illinois.
Today, Abbott Laboratories is one of the largest and most diversified healthcare companies in the world, with a presence in more than 160 countries. It is divided into four main business segments: Established Pharmaceuticals, Nutritionals, Medical Devices, and Diagnostics.
The company's pharmaceutical division focuses on developing and manufacturing prescription drugs for various therapeutic areas such as cardiovascular, neuroscience, and immunology. Its nutritional division is known for producing a wide range of nutritional products, including infant formula, adult nutrition, and diabetes care products.
Abbott Laboratories also has a significant presence in the medical device industry, producing products such as diabetes care devices, cardiovascular devices, and vision care products. Its diagnostics division offers a variety of laboratory instruments, reagents, and assays for the detection of diseases.
In addition to its core healthcare products, Abbott Laboratories also has a strong commitment to improving global health, particularly in developing countries. The company invests millions of dollars in programs and partnerships aimed at combating health issues like HIV/AIDS, malnutrition, and maternal and child health.
Overall, Abbott Laboratories has a long history of innovation and a strong commitment to improving people's lives through its products and initiatives. It continues to be a leader in the healthcare industry, constantly evolving and adapting to the changing needs of patients and healthcare providers.
How to explain to a 10 year old kid about the company?
Abbott Laboratories

πŸ“ˆ Want to read more about Abbott Laboratories?

Sign up for free or log in

πŸ‘₯ Free eBook for new users: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

QWJib3R0IE xhYm9yYXRv cmllcyBpcy BhIGJpZyBj b21wYW55IH RoYXQgaGVs cHMgcGVvcG xlIHN0YXkg aGVhbHRoeS 4gVGhleSBt YWtlIGxvdH Mgb2YgZGlm ZmVyZW50IH RoaW5ncyBs aWtlIG1lZG ljaW5lcywg c3BlY2lhbC Bmb29kIGZv ciBwZW9wbG Ugd2hvIG5l ZWQgZXh0cm EgaGVscCwg YW5kIHRvb2 xzIHRoYXQg ZG9jdG9ycy B1c2UgdG8g Y2hlY2sgaG 93IGhlYWx0 aHkgd2UgYX JlLiBGb3Ig ZXhhbXBsZS wgdGhleSBt YWtlIHRlc3 RzIHRvIGZp bmQgb3V0IG lmIHNvbWVv bmUgaXMgc2 ljayBhbmQg ZXZlbiBtYW NoaW5lcyB0 aGF0IGNhbi BoZWxwIGtl ZXAgb3VyIG hlYXJ0cyB3 b3JraW5nIH dlbGwuPGJy PkFiYm90dC BtYWtlcyBt b25leSBieS BzZWxsaW5n IHRoZXNlIH Byb2R1Y3Rz IHRvIGhvc3 BpdGFscywg ZG9jdG9ycy wgYW5kIHBo YXJtYWNpZX MuIFdoZW4g c29tZW9uZS BidXlzIHRo ZWlyIG1lZG ljaW5lIG9y IG1lZGljYW wgZXF1aXBt ZW50LCBBYm JvdHQgZ2V0 cyBwYWlkIG ZvciBpdC4g VGhleSBhbH NvIGNyZWF0 ZSBzcGVjaW FsIHByb2R1 Y3RzIGZvci BiYWJpZXMg YW5kIG90aG VyIHBlb3Bs ZSB3aG8gbm VlZCBoZWxw IHdpdGggdG hlaXIgZGll dHMuIEJlY2 F1c2UgdGhl eSBvZmZlci BtYW55IGRp ZmZlcmVudC BpdGVtcywg dGhleSBjYW 4gaGVscCBs b3RzIG9mIH Blb3BsZSBh bmQgbWFrZS Btb25leSBp biBtYW55IH dheXMuPGJy PkFiYm90dC BoYXMgYmVl biBzdWNjZX NzZnVsIGZv ciBhIGxvbm cgdGltZSBi ZWNhdXNlIH RoZXkgYWx3 YXlzIHRyeS B0byBpbnZl bnQgbmV3IG FuZCBiZXR0 ZXIgcHJvZH VjdHMuIFRo ZXkgYWxzby BtYWtlIHN1 cmUgdGhlaX IgcHJvZHVj dHMgYXJlIH JlYWxseSBn b29kIGFuZC BzYWZlLCB3 aGljaCBoZW xwcyBkb2N0 b3JzIGFuZC BwYXRpZW50 cyB0cnVzdC B0aGVtLiBJ biB0aGUgZn V0dXJlLCB0 aGV5IHdpbG wgbGlrZWx5 IGNvbnRpbn VlIHRvIGJl IHN1Y2Nlc3 NmdWwgYmVj YXVzZSB0aG V5IGtlZXAg cmVzZWFyY2 hpbmcgYW5k IGRldmVsb3 BpbmcgbmV3 IHRlY2hub2 xvZ3kgdG8g aGVscCBwZW 9wbGUsIGVz cGVjaWFsbH kgYXMgb3Vy IHdvcmxkIG hhcyBuZXcg aGVhbHRoIG NoYWxsZW5n ZXMuIFBlb3 BsZSB3aWxs IGFsd2F5cy BuZWVkIGhl bHAgc3RheW luZyBoZWFs dGh5LCBhbm QgYmVjYXVz ZSBBYmJvdH QgaXMgZ29v ZCBhdCBwcm 92aWRpbmcg dGhhdCBoZW xwLCB0aGV5 IHdpbGwgbG lrZWx5IGtl ZXAgZG9pbm cgd2VsbCBm b3IgeWVhcn MgdG8gY29t ZS48YnI+
What is special about the company?
Abbott Laboratories

πŸ“ˆ Want to read more about Abbott Laboratories?

Sign up for free or log in

πŸš€ Don’t miss "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

MS4gTG9uZy BIaXN0b3J5 OiBBYmJvdH QgTGFib3Jh dG9yaWVzIG hhcyBiZWVu IGluIGV4aX N0ZW5jZSBm b3Igb3Zlci AxMzAgeWVh cnMsIG1ha2 luZyBpdCBv bmUgb2YgdG hlIG9sZGVz dCBhbmQgbW 9zdCBlc3Rh Ymxpc2hlZC Bjb21wYW5p ZXMgaW4gdG hlIGhlYWx0 aGNhcmUgaW 5kdXN0cnku PGJyPjIuIE 11bHRpLVNw ZWNpYWx0eS BDb21wYW55 OiBBYmJvdH QgTGFib3Jh dG9yaWVzIG 9wZXJhdGVz IGluIGEgZG l2ZXJzZSBy YW5nZSBvZi BzZWN0b3Jz IGluY2x1ZG luZyBwaGFy bWFjZXV0aW NhbHMsIG1l ZGljYWwgZG V2aWNlcywg ZGlhZ25vc3 RpY3MsIGFu ZCBudXRyaX Rpb24sIGdp dmluZyB0aG UgY29tcGFu eSBhIHdpZG UgcmVhY2gg aW4gdGhlIG hlYWx0aGNh cmUgbWFya2 V0Ljxicj4z LiBHbG9iYW wgUHJlc2Vu Y2U6IFdpdG ggb3BlcmF0 aW9ucyBpbi Btb3JlIHRo YW4gMTYwIG NvdW50cmll cywgQWJib3 R0IExhYm9y YXRvcmllcy BoYXMgYSBz dHJvbmcgZ2 xvYmFsIHBy ZXNlbmNlLC BhbGxvd2lu ZyBpdCB0by BzZXJ2ZSBh IGRpdmVyc2 UgcmFuZ2Ug b2YgY3VzdG 9tZXJzIHdv cmxkd2lkZS 48YnI+NC4g U3Ryb25nIE ZvY3VzIG9u IFJlc2Vhcm NoIGFuZCBE ZXZlbG9wbW VudDogVGhl IGNvbXBhbn kgaGFzIGEg ZGVkaWNhdG VkIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudCB0ZW FtIHRoYXQg Zm9jdXNlcy BvbiBkZXZl bG9waW5nIG lubm92YXRp dmUgcHJvZH VjdHMgYW5k IHRlY2hub2 xvZ2llcyB0 byBhZGRyZX NzIHVubWV0 IG1lZGljYW wgbmVlZHMg YW5kIGltcH JvdmUgcGF0 aWVudCBvdX Rjb21lcy48 YnI+NS4gU3 Ryb25nIFBv cnRmb2xpby BvZiBQcm9k dWN0czogQW Jib3R0IExh Ym9yYXRvcm llcyBoYXMg YSBzdHJvbm cgcG9ydGZv bGlvIG9mIH Byb2R1Y3Rz LCBpbmNsdW RpbmcgcG9w dWxhciBicm FuZHMgc3Vj aCBhcyBTaW 1pbGFjLCBF bnN1cmUsIG FuZCBGcmVl c3R5bGUgTG licmUsIHdo aWNoIGFyZS B0cnVzdGVk IGJ5IGhlYW x0aGNhcmUg cHJvZmVzc2 lvbmFscyBh bmQgcGF0aW VudHMgd29y bGR3aWRlLj xicj42LiBD b21taXRtZW 50IHRvIFN1 c3RhaW5hYm lsaXR5OiBU aGUgY29tcG FueSBoYXMg YSBzdHJvbm cgY29tbWl0 bWVudCB0by BzdXN0YWlu YWJpbGl0eS BhbmQgaGFz IGltcGxlbW VudGVkIHZh cmlvdXMgaW 5pdGlhdGl2 ZXMgdG8gcm VkdWNlIGl0 cyBlbnZpcm 9ubWVudGFs IGltcGFjdC wgaW1wcm92 ZSBhY2Nlc3 MgdG8gaGVh bHRoY2FyZS wgYW5kIHN1 cHBvcnQgbG 9jYWwgY29t bXVuaXRpZX MuPGJyPjcu IEhpZ2gtUX VhbGl0eSBT dGFuZGFyZH M6IEFiYm90 dCBMYWJvcm F0b3JpZXMg aGFzIGEgcm VwdXRhdGlv biBmb3IgbW FpbnRhaW5p bmcgaGlnaC 1xdWFsaXR5 IHN0YW5kYX JkcyBpbiBp dHMgcHJvZH VjdHMgYW5k IHByb2Nlc3 NlcywgZW5z dXJpbmcgc2 FmZXR5IGFu ZCBlZmZpY2 FjeSBmb3Ig cGF0aWVudH MuPGJyPjgu IEZvY3VzIG 9uIEN1c3Rv bWVyIE5lZW RzOiBUaGUg Y29tcGFueS dzIGN1c3Rv bWVyLWNlbn RyaWMgYXBw cm9hY2ggaX MgcmVmbGVj dGVkIGluIG l0cyBjb21t aXRtZW50IH RvIG1lZXRp bmcgdGhlIG 5lZWRzIG9m IHBhdGllbn RzLCBoZWFs dGhjYXJlIH Byb2Zlc3Np b25hbHMsIG FuZCBvdGhl ciBzdGFrZW hvbGRlcnMu PGJyPjkuIF N0cm9uZyBG aW5hbmNpYW wgUGVyZm9y bWFuY2U6IE FiYm90dCBM YWJvcmF0b3 JpZXMgaGFz IGNvbnNpc3 RlbnRseSBk ZWxpdmVyZW Qgc3Ryb25n IGZpbmFuY2 lhbCBwZXJm b3JtYW5jZS wgbWFraW5n IGl0IGEgcm VsaWFibGUg YW5kIHN0YW JsZSBjb21w YW55IGZvci BpbnZlc3Rv cnMuPGJyPj EwLiBTdHJv bmcgQ29ycG 9yYXRlIEN1 bHR1cmU6IF RoZSBjb21w YW55IGhhcy BhIHN0cm9u ZyBjb3Jwb3 JhdGUgY3Vs dHVyZSB0aG F0IHZhbHVl cyBkaXZlcn NpdHksIGlu Y2x1c2lvbi wgYW5kIGVt cGxveWVlIH dlbGwtYmVp bmcsIG1ha2 luZyBpdCBh IGRlc2lyYW JsZSBwbGFj ZSB0byB3b3 JrIGZvciBl bXBsb3llZX Mu
What the company's business model?
Abbott Laboratories

πŸ“ˆ Want to read more about Abbott Laboratories?

Sign up for free or log in

⚑ Instantly access "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

VGhlIGNvcm UgYnVzaW5l c3MgbW9kZW wgb2YgQWJi b3R0IExhYm 9yYXRvcmll cyBpcyB0by BkZXZlbG9w LCBtYW51Zm FjdHVyZSwg YW5kIG1hcm tldCBhIGRp dmVyc2Ugcm FuZ2Ugb2Yg aGVhbHRoY2 FyZSBwcm9k dWN0cyBhbm Qgc2Vydmlj ZXMsIGluY2 x1ZGluZyBw aGFybWFjZX V0aWNhbHMs IG1lZGljYW wgZGV2aWNl cywgZGlhZ2 5vc3RpY3Ms IGFuZCBudX RyaXRpb24g cHJvZHVjdH MuIFRoZSBj b21wYW55IG 9wZXJhdGVz IGluIHNldm VyYWwgc2Vn bWVudHMsIG luY2x1ZGlu ZyBFc3RhYm xpc2hlZCBQ aGFybWFjZX V0aWNhbHMs IE1lZGljYW wgRGV2aWNl cywgTnV0cm l0aW9uLCBh bmQgRGlhZ2 5vc3RpY3Mu IDxicj5BYm JvdHQgTGFi b3JhdG9yaW VzJyBidXNp bmVzcyBzdH JhdGVneSBm b2N1c2VzIG 9uIGlubm92 YXRpb24gYW 5kIGFjcXVp c2l0aW9uIH RvIGV4cGFu ZCBpdHMgcH JvZHVjdCBw b3J0Zm9saW 8gYW5kIGVu dGVyIG5ldy BtYXJrZXRz LiBUaGUgY2 9tcGFueSBp bnZlc3RzIG hlYXZpbHkg aW4gcmVzZW FyY2ggYW5k IGRldmVsb3 BtZW50IHRv IGRldmVsb3 AgbmV3IGFu ZCBpbm5vdm F0aXZlIGhl YWx0aGNhcm Ugc29sdXRp b25zLCB3aG ljaCBhcmUg dGhlbiBtYX JrZXRlZCBn bG9iYWxseS 4gQWRkaXRp b25hbGx5LC BBYmJvdHQg TGFib3JhdG 9yaWVzIGFj cXVpcmVzIG 90aGVyIGNv bXBhbmllcy B0byBkaXZl cnNpZnkgaX RzIHByb2R1 Y3Qgb2ZmZX JpbmdzIGFu ZCBleHBhbm QgaXRzIGds b2JhbCBwcm VzZW5jZS4g PGJyPlRoZS Bjb21wYW55 IGFsc28gaG FzIGEgc3Ry b25nIGZvY3 VzIG9uIGZp bmFuY2lhbC BkaXNjaXBs aW5lLCBjb3 N0IGNvbnRy b2wsIGFuZC BvcGVyYXRp b25hbCBlZm ZpY2llbmN5 IHRvIGRyaX ZlIHByb2Zp dGFiaWxpdH kgYW5kIGxv bmctdGVybS Bncm93dGgu IEl0cyBleH RlbnNpdmUg ZGlzdHJpYn V0aW9uIG5l dHdvcmsgYW 5kIHBhcnRu ZXJzaGlwcy B3aXRoIGhl YWx0aGNhcm UgcHJvdmlk ZXJzIGFuZC Bnb3Zlcm5t ZW50cyBlbm FibGUgaXQg dG8gcmVhY2 ggYSB3aWRl IGN1c3RvbW VyIGJhc2Ug YW5kIGVuc3 VyZSB0aGUg YXZhaWxhYm lsaXR5IG9m IGl0cyBwcm 9kdWN0cyBh bmQgc2Vydm ljZXMuIDxi cj5PdmVyYW xsLCBBYmJv dHQgTGFib3 JhdG9yaWVz JyBidXNpbm VzcyBtb2Rl bCBjZW50ZX JzIG9uIHBy b3ZpZGluZy BxdWFsaXR5 IGFuZCBpbm 5vdmF0aXZl IGhlYWx0aG NhcmUgc29s dXRpb25zIH doaWxlIGV4 cGFuZGluZy BpdHMgZ2xv YmFsIHJlYW NoIHRocm91 Z2ggYSBjb2 1iaW5hdGlv biBvZiBvcm dhbmljIGdy b3d0aCBhbm Qgc3RyYXRl Z2ljIGFjcX Vpc2l0aW9u cy4=
Is AI a threat?
AI does pose potential challenges to Abbott Laboratories in several ways.
Firstly, substitution could occur if AI-driven innovations lead to alternative health solutions that compete with Abbott’s products. For instance, advancements in telemedicine and digital health platforms could offer consumers alternative diagnostics or health management tools that reduce reliance on traditional medical devices and tests that Abbott provides.
Secondly, disintermediation may happen as AI technologies streamline processes, connecting healthcare providers directly with patients. This shift could lessen the role of intermediaries and traditional healthcare channels that Abbott relies on for distribution and supply of its products.
Lastly, margin pressure could arise due to increased competition from tech companies entering the healthcare space. As AI lowers the costs of developing and delivering certain healthcare applications, it could compress the margins on Abbott’s products if they face pressure to reduce prices in response.
In summary, while AI can offer opportunities for innovation and efficiency, it also presents material threats to Abbott Laboratories through substitution of their products, potential disintermediation in healthcare delivery, and increased margin pressure resulting from heightened competition.
Sensitivity to interest rates
The sensitivity of Abbott Laboratories’ earnings, cash flow, and valuation to changes in interest rates can be understood through several key factors:
1. Debt Levels: If Abbott has significant outstanding debt, rising interest rates can lead to increased interest expenses. This can adversely affect net earnings and cash flow, especially if the company is unable to pass on these costs to consumers through higher prices.
2. Cost of Capital: Interest rates impact the overall cost of capital. Higher rates can lead to a higher discount rate in discounted cash flow (DCF) valuation models, which can decrease the present value of future cash flows. As a result, an increase in interest rates may lower Abbott’s valuation.
3. Consumer Spending: In a high-interest-rate environment, consumers may reduce spending on health-related products and services, which could directly impact Abbott’s sales and revenue growth. This effect can vary depending on the specific segment of Abbott’s business, such as medical devices, diagnostics, or nutrition.
4. Investment in R&D: Changes in interest rates can affect Abbott’s decisions regarding capital expenditures and investment in research and development. Higher borrowing costs might lead to more stringent capital allocation, potentially impacting long-term growth and innovation.
5. Market Sentiment: Interest rates influence overall market sentiment and investor behavior. Rising rates may lead to a shift in investment strategies, with investors potentially favoring less volatile investments (like bonds) over equities, including those of Abbott.
6. Foreign Exposure: Abbott operates globally, and changes in interest rates can also affect foreign exchange rates. If interest rates rise in the U.S., it could strengthen the dollar, making Abbott’s international sales less competitive.
Overall, Abbott Laboratories’ earnings, cash flow, and valuation are sensitive to changes in interest rates due to their impact on borrowing costs, consumer behavior, market conditions, and investment strategy.
Resilience to the future changes
Abbott Laboratories

πŸ“ˆ Want to read more about Abbott Laboratories?

Sign up for free or log in

πŸ“– Get insights from "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" now!

QSByZWFsaX N0aWMgc2Nl bmFyaW8gdG hhdCBjb3Vs ZCBwZXJtYW 5lbnRseSBp bXBhaXIgQW Jib3R0IExh Ym9yYXRvcm llc+KAmSBl Y29ub21pY3 Mgb3ZlciB0 aGUgbmV4dC AzLTUgeWVh cnMgaXMgdG hlIHNpZ25p ZmljYW50IG FuZCBwcm9s b25nZWQgZG VjbGluZSBp biBkZW1hbm QgZm9yIGl0 cyBlc3RhYm xpc2hlZCBw cm9kdWN0IG xpbmVzLCBw YXJ0aWN1bG FybHkgaW4g ZGlhZ25vc3 RpY3MsIG1l ZGljYWwgZG V2aWNlcywg YW5kIG51dH JpdGlvbiBw cm9kdWN0cy wgZHVlIHRv IG1hcmtldC BzYXR1cmF0 aW9uLCBpbm NyZWFzZWQg Y29tcGV0aX Rpb24sIG9y IHJlZ3VsYX RvcnkgY2hh bGxlbmdlcy 4gPGJyPjEu IDxzdHJvbm c+TWFya2V0 IFNhdHVyYX Rpb24gYW5k IENvbXBldG l0aW9uPC9z dHJvbmc+Oi BBYmJvdHQg b3BlcmF0ZX MgaW4gaGln aGx5IGNvbX BldGl0aXZl IHNlY3Rvcn MsIGFuZCBp ZiBhIG5ldy BlbnRyYW50 IG9yIGRpc3 J1cHRpdmUg dGVjaG5vbG 9neSBzaWdu aWZpY2FudG x5IGNhcHR1 cmVzIG1hcm tldCBzaGFy ZSwgdGhlIG NvbXBhbnkg Y291bGQgZm FjZSBkZWNs aW5pbmcgc2 FsZXMuIEZv ciBleGFtcG xlLCBpZiBh IGNvbXBldG l0b3IgaW50 cm9kdWNlZC BhIGNoZWFw ZXIgb3IgbW 9yZSBlZmZl Y3RpdmUgZG lhZ25vc3Rp YyB0b29sIH RoYXQgYmVj YW1lIHRoZS BpbmR1c3Ry eSBzdGFuZG FyZCwgQWJi b3R04oCZcy BtYXJrZXQg c2hhcmUgY2 91bGQgZGlt aW5pc2guPG JyPjIuIDxz dHJvbmc+Um VndWxhdG9y eSBDaGFsbG VuZ2VzPC9z dHJvbmc+Oi BGdXJ0aGVy IHJlZ3VsYX Rvcnkgc2Ny dXRpbnkgb3 Igc3RyaWN0 ZXIgY29tcG xpYW5jZSBy ZXF1aXJlbW VudHMgY291 bGQgbGVhZC B0byBpbmNy ZWFzZWQgY2 9zdHMgYW5k IGRlbGF5cy BpbiBwcm9k dWN0IGxhdW 5jaGVzLiBJ ZiBBYmJvdH QgZmFjZWQg c2lnbmlmaW NhbnQgcGVu YWx0aWVzIG 9yIHNhbmN0 aW9ucyBkdW UgdG8gY29t cGxpYW5jZS Bpc3N1ZXMs IHRoaXMgY2 91bGQgc2V2 ZXJlbHkgaW 1wYWN0IHBy b2ZpdGFiaW xpdHkuPGJy PjMuIDxzdH Jvbmc+RWNv bm9taWMgRG 93bnR1cm48 L3N0cm9uZz 46IEEgZ2xv YmFsIGVjb2 5vbWljIHJl Y2Vzc2lvbi Bjb3VsZCBy ZWR1Y2UgaG VhbHRoY2Fy ZSBzcGVuZG luZyBhcyBo b3NwaXRhbH MgYW5kIGNv bnN1bWVycy BjdXQgYmFj ayBvbiBub2 Vzc2VudGlh bCBtZWRpY2 FsIHByb2Nl ZHVyZXMgYW 5kIHByb2R1 Y3RzLiBGb3 IgQWJib3R0 LCB0aGlzIG NvdWxkIGxl YWQgdG8gYS ByZWR1Y3Rp b24gaW4gYm 90aCBzYWxl cyByZXZlbn VlIGFuZCBw cm9maXQgbW FyZ2lucy48 YnI+SWYgc3 VjaCBhIHNj ZW5hcmlvIH BsYXllZCBv dXQsIHRoZS BpbXBhY3Rz IG9uIEFiYm 90dOKAmXMg ZmluYW5jaW FscyBjb3Vs ZCBiZSBzdW JzdGFudGlh bDo8YnI+LS A8c3Ryb25n Pk1hcmdpbn M8L3N0cm9u Zz46IFRoZS Bjb21wYW55 4oCZcyBwcm 9maXQgbWFy Z2lucyB3b3 VsZCBsaWtl bHkgc2hyaW 5rIGR1ZSB0 byBpbmNyZW FzZWQgY29t cGV0aXRpb2 4gbGVhZGlu ZyB0byBwcm ljZSBwcmVz c3VyZSBhbm QgcG90ZW50 aWFsbHkgaG lnaGVyIG9w ZXJhdGlvbm FsIGNvc3Rz IHRvIGNvbX BseSB3aXRo IHJlZ3VsYX RvcnkgZGVt YW5kcy4gVG hpcyBzY2Vu YXJpbyBjb3 VsZCBzZWUg Z3Jvc3MgbW FyZ2lucyBk ZWNsaW5lIH NpZ25pZmlj YW50bHksIH dpdGggb3Bl cmF0aW5nIG 1hcmdpbnMg dW5kZXIgZn VydGhlciBw cmVzc3VyZS Bmcm9tIGZp eGVkIGNvc3 RzIHRoYXQg cmVtYWluIH VuY2hhbmdl ZCB3aGlsZS ByZXZlbnVl IGRlY2xpbm VzLjxicj4t IDxzdHJvbm c+Q2FzaCBG bG93PC9zdH Jvbmc+OiBD YXNoIGZsb3 cgZnJvbSBv cGVyYXRpb2 5zIGNvdWxk IGRpbWluaX NoIHNoYXJw bHkgYXMgcm V2ZW51ZSBk ZWNsaW5lcy wgcG90ZW50 aWFsbHkgbG VhZGluZyBB YmJvdHQgdG 8gYSBzaXR1 YXRpb24gd2 hlcmUgaXQg bWlnaHQgc3 RydWdnbGUg dG8gZnVuZC BvcGVyYXRp b25hbCBjb3 N0cyBvciBp bnZlc3QgaW 4gbmV3IHBy b2R1Y3QgZG V2ZWxvcG1l bnQuIE5lZ2 F0aXZlIGNh c2ggZmxvd3 MgY291bGQg bGVhZCB0by BjdXRiYWNr cyBpbiBjYX BpdGFsIGV4 cGVuZGl0dX JlcyBhbmQg cmVzZWFyY2 ggYW5kIGRl dmVsb3BtZW 50LCBmdXJ0 aGVyIGV4YW NlcmJhdGlu ZyB0aGUgZG VjbGluZSBp biBmdXR1cm UgY29tcGV0 aXRpdmVuZX NzLjxicj4t IDxzdHJvbm c+QmFsYW5j ZSBTaGVldD wvc3Ryb25n PjogVGhlIG JhbGFuY2Ug c2hlZXQgd2 91bGQgcmVm bGVjdCBpbm NyZWFzZWQg ZmluYW5jaW FsIHN0cmFp bi4gQW4gb2 5nb2luZyBk ZWNsaW5lIG luIHJldmVu dWUgY291bG QgbGVhZCB0 byByZWR1Y2 VkIGNhc2gg cmVzZXJ2ZX MsIGluY3Jl YXNpbmcgcm VsaWFuY2Ug b24gZGVidC B0byBzdXN0 YWluIG9wZX JhdGlvbnMu IElmIGNhc2 ggZmxvdyB3 ZXJlIGluc3 VmZmljaWVu dCwgdGhlIG NvbXBhbnkg bWF5IHNlZS BoaWdoZXIg ZGVidCBsZX ZlbHMgd2l0 aG91dCBjb3 JyZXNwb25k aW5nIGFzc2 V0IGdyb3d0 aC4gSWYgbG 9zc2VzIGNv bnRpbnVlZC BvdmVyIG11 bHRpcGxlIH F1YXJ0ZXJz LCBBYmJvdH QgY291bGQg ZXhwZXJpZW 5jZSBhIGRl dGVyaW9yYX Rpb24gb2Yg a2V5IGZpbm FuY2lhbCBy YXRpb3MsIG luY3JlYXNp bmcgbGV2ZX JhZ2UgcmF0 aW9zIGFuZC Bwb3RlbnRp YWxseSBpbX BhY3Rpbmcg aXRzIGNyZW RpdCByYXRp bmdzLjxicj 5JbiBzdW1t YXJ5LCBpZi BBYmJvdHQg TGFib3JhdG 9yaWVzIHdl cmUgdG8gZm FjZSBhIHBy b2xvbmdlZC BkZWNsaW5l IGluIGRlbW FuZCBmb3Ig aXRzIGtleS Bwcm9kdWN0 IGxpbmVzIG R1ZSB0byBt YXJrZXQgc2 F0dXJhdGlv biwgc2lnbm lmaWNhbnQg Y29tcGV0aX Rpb24sIG9y IHJlZ3VsYX RvcnkgaHVy ZGxlcywgdG hlIGNvbXBh bnkgY291bG QgZXhwZXJp ZW5jZSByZW R1Y2VkIHBy b2ZpdCBtYX JnaW5zLCBu ZWdhdGl2ZS BjYXNoIGZs b3csIGFuZC BhIHdlYWtl bmVkIGJhbG FuY2Ugc2hl ZXQsIHdoaW NoIGluIHR1 cm4gd291bG QgaW1wYWly IGl0cyBsb2 5nLXRlcm0g ZWNvbm9taW NzLjxicj4=
Interesting facts about the company
Abbott Laboratories

πŸ“ˆ Want to read more about Abbott Laboratories?

Sign up for free or log in

πŸ“˜ Claim your free eBook: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvMW VnWkFwdHRC bjhOcERNTE xQaHMud2Vi cCIgYWx0PS JBYmJvdHQg TGFib3JhdG 9yaWVzIiB0 aXRsZT0iQW Jib3R0IExh Ym9yYXRvcm llcyIgIGNs YXNzPSJpbW ctZmx1aWQi IGhlaWdodD 01MCB3aWR0 aD01MCBsb2 FkaW5nPSds YXp5JyBzdH lsZT0nYm9y ZGVyLXJhZG l1czogNnB4 Oyc+CgogIC AgICAgICAg ICAgICAgIC AgIDxkaXYg c3R5bGU9J2 ZsZXg6IDE7 IHRleHQtYW xpZ246IGNl bnRlcjsgbW FyZ2luLWxl ZnQ6IDVweD snPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n Zm9udC1zaX plOiAyNnB4 OyBjb2xvcj ogIzMzMzsg bWFyZ2luLW JvdHRvbTog MTVweDsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg8J +TiCBXYW50 IHRvIHJlYW QgbW9yZSBh Ym91dCBBYm JvdHQgTGFi b3JhdG9yaW VzPwogICAg ICAgICAgIC AgICAgICAg ICAgICA8L3 A+CgogICAg ICAgICAgIC AgICAgICAg ICAgICA8YS BocmVmPSdp bmRleC5waH A/cGFnZT1z aWdudXAnIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJh Y2tncm91bm QtY29sb3I6 ICMwMDdCRk Y7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bjb2xvcjog I2ZmZjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHBhZG Rpbmc6IDEw cHggMjBweD sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG JvcmRlci1y YWRpdXM6ID VweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHRleHQt ZGVjb3JhdG lvbjogbm9u ZTsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGZvbnQtd2 VpZ2h0OiBi b2xkOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbWFyZ2 luLXJpZ2h0 OiAxMHB4Ow ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgdH JhbnNpdGlv bjogYmFja2 dyb3VuZC1j b2xvciAwLj NzIGVhc2U7 JwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg b25tb3VzZW 92ZXI9J3Ro aXMuc3R5bG UuYmFja2dy b3VuZENvbG 9yPSIjMDA1 NmIzIicKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIG9ubW 91c2VvdXQ9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA3QkZGIi c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BTaWduIHVw IGZvciBmcm VlCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxzcG FuIHN0eWxl PSdtYXJnaW 46IDAgOHB4 OyBjb2xvcj ogIzU1NTsn Pm9yPC9zcG FuPgoKICAg ICAgICAgIC AgICAgICAg ICAgICAgPG EgaHJlZj0n aW5kZXgucG hwP3BhZ2U9 bG9naW4nIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGNv bG9yOiAjMD A3QkZGOwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdGV4 dC1kZWNvcm F0aW9uOiB1 bmRlcmxpbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogNT AwOyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBsb2cg aW4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9h PgoKCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxw IHN0eWxlPS dtYXJnaW4t dG9wOiAxNX B4OyBmb250 LXNpemU6ID EzcHg7IGZv bnQtd2VpZ2 h0OiBib2xk OyBjb2xvcj ogI2QzMmYy ZjsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAg8J+Tmi BZb3VyIGZy ZWUgY29weS BvZiA8aT4i VGhlIENoZW NrbGlzdCBW YWx1ZSBJbn Zlc3RvciDi gJQgQSBTbW FydGVyIFdh eSB0byBQaW NrIFN0b2Nr cyI8L2k+IG lzIHdhaXRp bmcKICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPCEt LQogICAgIC AgICAgICAg ICAgICAgIC AgICA8ZGl2 IHN0eWxlPS dtYXJnaW4t dG9wOiAxMn B4OyBmb250 LXNpemU6ID EzcHg7IGNv bG9yOiAjND Q0Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIG5vdy BhbmQgZ2V0 IG91ciBmcm VlIGVCb29r IAogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg PGI+VGhlIE NoZWNrbGlz dCBWYWx1ZS BJbnZlc3Rv ciDigJQgQS BTbWFydGVy IFdheSB0by BQaWNrIFN0 b2NrczwvYj 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIC0tPg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8IS0tCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxkaXYgc3 R5bGU9J21h cmdpbi10b3 A6IDE2cHg7 IGZvbnQtc2 l6ZTogMTRw eDsgY29sb3 I6ICM0NDQ7 IGZvbnQtZm FtaWx5OiAt YXBwbGUtc3 lzdGVtLCBC bGlua01hY1 N5c3RlbUZv bnQsIFNlZ2 9lIFVJLCBS b2JvdG8sIE hlbHZldGlj YSBOZXVlLC BzYW5zLXNl cmlmOyBsaW 5lLWhlaWdo dDogMS42Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BIYXZlIHlv dSBoZWFyZC BhYm91dCBv dXIgc2hvcn QgPHN0cm9u ZyBzdHlsZT 0nZm9udC13 ZWlnaHQ6ID YwMDsnPkRh aWx5IFZpZG VvIE5ld3Ns ZXR0ZXI8L3 N0cm9uZz4/ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICA8 YSBocmVmPS dodHRwczov L3d3dy5pbn NpZ2h0ZnVs dmFsdWUuY2 9tL25ld3Ns ZXR0ZXIucG hwJyB0YXJn ZXQ9J19ibG Fuaycgc3R5 bGU9J2NvbG 9yOiAjMDA3 QkZGOyB0ZX h0LWRlY29y YXRpb246IG 5vbmU7IGZv bnQtd2VpZ2 h0OiA1MDA7 IG1hcmdpbi 1sZWZ0OiA2 cHg7Jz4KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BGaW5kIG91 dCBtb3JlCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICA8L2 E+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgICAg ICAgICAtLT 4KICAgICAg ICAgICAgIC AgICAgICA8 L2Rpdj4KIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg CiAgICAgIC AgCiAgICAg ICAgPHNwYW 4gY2xhc3M9 J2JsdXJyZW QtdGV4dCc+ CiAgICAgIC AgICAgIE1T NGdRV0ppYj MgUjBJRXho WW05eSBZWF J2Y21sbGN5 IEIzWVhNZ1 ptOTEgYm1S bFpDQnBiaS BBeE9EZzRJ R0o1IElFUn lMaUJYWVcg eHNZV05sSU VNdSBJRUZp WW05MGRDIH dnZDJodklI ZGggY3lCaE lFTm9hVyBO aFoyOGdjR2 g1IGMybGph V0Z1SUcgRn VaQ0J3YUdG eSBiV0ZqYV hOMExpIEJK Ym1sMGFXRn MgYkhrc0lI Um9aUyBCam IyMXdZVzU1 IElIZGhjeU JtYjIgTjFj MlZrSUc5dS BJRzFoYm5W bVlXIE4wZF hKcGJtY2cg WkhKMVozTW dZVyA1a0lI QnliMlIxIF kybHVaeUJp YjMgUmhibW xqWVd3ZyBa WGgwY21Gam RIIE1zSUdK MWRDQnAgZE NCc1lYUmxj aSBCbGVIQm hibVJsIFpD QnBiblJ2SU cgSnNiMjlr SUdkcyBkV0 52YzJVZ2JX IDl1YVhSdm NtbHUgWnl3 Z2JuVjBjbS BsMGFXOXVJ SEJ5IGIyUj FZM1J6TEMg QnRaV1JwWT JGcyBJR1Js ZG1salpYIE 1zSUdGdVpD QmsgYVdGbm JtOXpkRyBs amN5NDhZbk krIE1pNGdW R2hsSUcgTn ZiWEJoYm5u aSBnSmx6SU dacGNuIE4w SUcxaGFtOX kgSUdKeVpX RnJkRyBoeW IzVm5hQ0Jq IFlXMWxJR2 x1SUQgRTRP VE1zSUhkby BaVzRnYVhR Z1pHIFYyWl d4dmNHVmsg SUdFZ2JXVm thVyBOcGJt VWdZMkZzIG JHVmtJSFJv WlMgQkJZbU p2ZEhRZyBR V3hyWVd4dm FXIFJoYkNC RGIyMXcgWV c1NTRvQ1pj eSBCTlpXUn BZMmx1IFlX d2dSR2xuWl ggTjBhWFps SUVWcyBhWG hwY2k0Z1ZH IGhwY3lCdF pXUnAgWTJs dVpTQmlaVy BOaGJXVWdk MmxrIFpXeD VJSEJ2Y0gg VnNZWElnWm 05eSBJSEps YkdsbGRtIG x1WnlCd1lX bHUgSUdGdV pDQnBiWCBC eWIzWnBibW NnIFpHbG5a WE4wYVcgOX VMQ0JoYm1R ZyBhWFFnYU dWc2NHIFZr SUhCMWRDQk IgWW1KdmRI UWdURyBGaW IzSmhkRzl5 IGFXVnpJRz l1SUggUm9a U0J0WVhBdS BQR0p5UGpN dUlFIGx1SU RFNU1ETXMg SUVGaVltOT BkQyBCTVlX SnZjbUYwIG IzSnBaWE1n WW0gVmpZVz FsSUc5dSBa U0J2WmlCMG FHIFVnWm1s eWMzUWcgWT I5dGNHRnVh VyBWeklIUn ZJSEJ5IGIy UjFZMlVnWV MgQnpkR0Z1 WkdGeSBaR2 w2WldRZ1pt IDl5YlNCdl ppQmsgYVdk cGRHRnNhWC BNc0lHRWdh R1ZoIGNuUW diV1ZrYVcg TmhkR2x2Ym k0ZyBWR2hw Y3lCb1pXIH h3WldRZ2Nt VjIgYjJ4MW RHbHZibSBs NlpTQjBhR1 VnIGRISmxZ WFJ0WlcgNT BJRzltSUdo bCBZWEowSU dScGMyIFZo YzJVdVBHSn kgUGpRdUlF UjFjbSBsdV p5QlhiM0pz IFpDQlhZWE lnU1Uga3NJ RUZpWW05MC BkQ0JNWVdK dmNtIEYwYj NKcFpYTWcg Y0hKdlpIVm paVyBRZ1lX NGdaWGh3IF pYSnBiV1Z1 ZEcgRnNJR1 J5ZFdjcyBJ SEJsYm1sam FXIHhzYVc0 c0lHbHUgSU d4aGNtZGxJ SCBGMVlXNT BhWFJwIFpY TXVJRlJvYV ggTWdkMkZ6 SUhWeiBaV1 FnZEc4Z2RI IEpsWVhRZ2 QyOTEgYm1S bFpDQnpiMi B4a2FXVnlj eUJ2IGJpQj BhR1VnWm4g SnZiblFnYk dsdSBaWE1z SUdobGJIIE JwYm1jZ2RH OGcgYzJGMl pTQnRZVyA1 NUlHeHBkbV Z6IExqeGlj ajQxTGkgQk JZbUp2ZEhR ZyBUR0ZpYj NKaGRHIDl5 YVdWeklHaG ggY3lCaElH eHZibSBjZ2 FHbHpkRzl5 IGVTQnZaaU JrWlggWmxi Rzl3YVc1bi BJR2x1Ym05 MllYIFJwZG 1VZ2JXVmsg YVdOaGJDQm taWCBacFky VnpMaUJKIG JpQXhPVFUw TEMgQjBhR1 VnWTI5dCBj R0Z1ZVNCcG JuIFJ5YjJS MVkyVmsgSU hSb1pTQm1h WCBKemRDQn RZWE56IExY QnliMlIxWT IgVmtJR0pz YjI5ayBJR2 RzZFdOdmMy IFVnYldWMF pYSXMgSUhk b2FXTm9JSC BKbGRtOXNk WFJwIGIyNX BlbVZrSUcg UnBZV0psZE dWeiBJRzFo Ym1GblpXID FsYm5RdVBH SnkgUGpZdU lFbHVJRCBJ d01URXNJRU ZpIFltOTBk Q0JNWVcgSn ZjbUYwYjNK cCBaWE1nYz NCc2FYIFFn YVc1MGJ5Qj AgZDI4Z2My VndZWCBKaG RHVWdZMjl0 IGNHRnVhV1 Z6T2kgQkJZ bUp2ZEhRcy BJSGRvYVdO b0lHIFp2WT NWelpYTWcg YjI0Z2JXVm thVyBOaGJD QmtaWFpwIF kyVnpMQ0Jr YVcgRm5ibT l6ZEdsaiBj eXdnWVc1a0 lHIDUxZEhK cGRHbHYgYm lCd2NtOWtk VyBOMGN5d2 dZVzVrIElF RmlZbFpwWl Mgd2dkMmhw WTJnZyBabT lqZFhObGN5 IEJ2YmlCd2 FHRnkgYldG alpYVjBhVy BOaGJITXVQ R0p5IFBqY3 VJRUZpWW0g OTBkQ0JNWV dKdiBjbUYw YjNKcFpYIE 1nYUdGeklH MWggWkdVZ2 MyVjJaWCBK aGJDQnViM1 JoIFlteGxJ R0ZqY1ggVn BjMmwwYVc5 dSBjeUJ2ZG 1WeUlIIFJv WlNCNVpXRn kgY3l3Z2FX NWpiSCBWa2 FXNW5JSFJv IFpTQndhR0 Z5YlcgRmpa WFYwYVdOaC BiQ0JqYjIx d1lXIDU1SU VGc2VtRWcg UTI5eWNHOX lZWCBScGIy NGdhVzRnIE 1qQXdNU0Jo Ym0gUWdkR2 hsSUc1MSBk SEpwZEdsdm JpIEJqYjIx d1lXNTUgSU U1bGMzUnNa ZSBLQW1YTW dhVzVtIFlX NTBJRzUxZE ggSnBkR2x2 YmlCayBhWF pwYzJsdmJp IEJwYmlBeU 1ERTMgTGp4 aWNqNDRMaS BCVWFHVWdZ Mjl0IGNHRn VlU0JvWVgg TWdZU0J6ZE hKdiBibWNn WjJ4dlltIE ZzSUhCeVpY TmwgYm1ObE xDQjNhWCBS b0lHOXdaWE poIGRHbHZi bk1nYVcgNG diM1psY2lB eCBOakFnWT I5MWJuIFJ5 YVdWeklHRn UgWkNCd2Nt OWtkVyBOMG N5QnpiMnhr IElHbHVJRz F2Y20gVWdk R2hoYmlBeC BOakF1UEdK eVBqIGt1SU VsdUlESXcg TVRZc0lFRm lZbSA5MGRD Qk1ZV0p2IG NtRjBiM0pw WlggTWdiV0 ZrWlNCaCBJ RzFoYW05eU lHIEp5WldG cmRHaHkgYj NWbmFDQnBi aSBCMGFHVW dabWxsIGJH UWdiMllnWk cgbGhaMjV2 YzNScCBZM0 1nZDJsMGFD IEIwYUdVZ1 pHVjIgWld4 dmNHMWxibi BRZ2IyWWdZ U0J5IFlYQn BaQ0IwWlgg TjBJR1p2Y2 lCMCBhR1Vn V21scllTIE IyYVhKMWN5 NGcgVkdocG N5QjBaWCBO MElHTnZkV3 hrIElIQnli M1pwWkcgVW djbVZ6ZFd4 MCBjeUJwYm lCcWRYIE4w SUdacGRtVW cgZEc4Z2My VjJaVyA0Z1 pHRjVjeXdn IFkyOXRjR0 Z5WlcgUWdk RzhnZDJWbC BhM01nZDJs MGFDIEIwY2 1Ga2FYUnAg YjI1aGJDQj BaWCBOMGFX NW5JRzFsIG RHaHZaSE11 UEcgSnlQak V3TGlCQiBZ bUp2ZEhRZ1 RHIEZpYjNK aGRHOXkgYV dWeklHbHpJ RyBOdmJXMX BkSFJsIFpD QjBieUJ6ZF ggTjBZV2x1 WVdKcCBiR2 wwZVNCaGJt IFFnYUdGek lITmwgZENC bmIyRnNjeS BCMGJ5Qnla V1IxIFkyVW dhWFJ6SUcg TmhjbUp2Ym lCbSBiMjkw Y0hKcGJuIF FzSUdsdVkz SmwgWVhObE lHVnVaWCBK bmVTQmxabV pwIFkybGxi bU41TEMgQm hibVFnWkdW aiBjbVZoYz JVZ2QyIEYw WlhJZ2RYTm ggWjJVdUlG Um9aUyBCam IyMXdZVzU1 IElHaGhjeU JoYkggTnZJ R2x0Y0d4bC BiV1Z1ZEdW a0lIIEpsWT NsamJHbHUg WnlCd2NtOW 5jbSBGdGN5 QmhibVFnIG FYTWdZMjl1 ZEcgbHVkVz kxYzJ4NSBJ SGR2Y210cG JtIGNnZEc4 Z2NtVmsgZF dObElIZGhj MyBSbElHbH VJR2wwIGN5 QnZjR1Z5WV ggUnBiMjV6 TGc9PQogIC AgICAgIDwv c3Bhbj4KIC AgICAgICAK ICAgICAgIC A=
See Company Q&A
Abbott Laboratories

πŸ“Š Get full analytics about Abbott Laboratories

Sign up for free or log in

πŸ™Œ Join now to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" at no cost

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal